On August 18, the "Prologue to Glory—2025 CPEO Awards Ceremony" was grandly held. As a leader in modern Chinese medicine, Da Ren Tang's classic product Quick-Acting Heart Rescue Pill earned industry-wide recognition for its outstanding comprehensive competitiveness, securing a spot on the "2025 Healthy China Brand List" and receiving the industry's highest honor—the CPEO Awards!

The "Healthy China Brand List" evaluates brand comprehensive strength through a 4D-BES system, focusing on four core dimensions: product value, market value, profit potential, and user acclaim. Da Ren Tang Quick-Acting Heart Rescue Pills stood out among numerous products due to their remarkable clinical efficacy, extensive market coverage, and deep user trust.

 As a state-protected proprietary formula, Quick-acting Heart Reliever Pill embody the essence of traditional Chinese medicine, offering benefits that "promote qi circulation, activate blood flow, dispel blood stasis, and relieve pain." Its instructions explicitly state the function of "increasing coronary blood flow," enabling rapid relief from chest tightness and pain.

Over its 40-year market presence, Da Ren Tang Quick-Acting Heart Rescue Pill have surpassed cumulative sales of 100 billion pills, becoming a "life-saving medicine" stocked in households and medical institutions.

Academician Zhang Boli's advocacy for the principle "Better to take it regularly than to take it when needed" has expanded its use from emergency treatment to daily maintenance, highlighting TCM's unique advantages in treating cardiovascular diseases.

Winning the CPEO Awards represents both the industry's high recognition of Tianjin Pharmaceuticals Group's brand strength and affirmation of the efficacy and safety of Quick-acting Heart Reliever Pill. As a leader in modern Chinese medicine, Tianjin Pharmaceuticals Group will seize this opportunity to deepen the preservation and innovation of traditional Chinese medicine, contributing more wisdom and strength to the "Healthy China" initiative.